Iris Acquisition Corp
liminatuspharma.comNo Longer Reporting
The company has not filed an annual or quarterly report since its FY2024 10-K, filed Apr 16, 2025. Its latest SEC filing is a 15-12G from Apr 30, 2025.
10-K for FY2024, filed Apr 16, 2025
The sections below describe the company as of the FY2024 annual report.
What Did They Do?
Seeks a merger, acquisition or similar combination with a target business, using capital raised through public and private securities offerings.
10-K for FY2024, filed Apr 16, 2025Iris Acquisition Corp (“we,” “us,” “our,” the “Company” or “Iris”) is a blank check company incorporated on November 5, 2020 as a Delaware…View ↗
The registration statement for our initial public offering was declared effective on March 4, 2021. On March 9, 2021, Iris consummated the…View ↗
Simultaneously with the closing of the IPO, pursuant to the Warrant Purchase Agreements, the Company completed the private sale of an…View ↗
How Did They Make Money?
No revenue was reported.
10-K for FY2024, filed Apr 16, 2025
Loading...
